Ran Frenkel

Ran Frenkel serves as the Chief Executive Officer of Polaroid Therapeutics since December 2022. Prior to this role, Ran was a member of the Advisory Board for Musli Thyropeutics Ltd., contributing to initiatives targeting aggressive cancers such as Glioblastoma Multiforme. Ran's extensive experience includes serving as Executive Vice President, Worldwide Development Operations, and Executive VP & Chief Development Officer at Karyopharm Therapeutics Inc. from October 2014 to December 2022. Additionally, Ran held positions such as Executive Board Member and Director of European Liaison at IISRA, Managing Director at Clinipace Worldwide, and Managing Director of Actelion Pharmaceuticals Israel. Earlier in the career, Ran directed the Clinical Research Center at Sheba Medical Center. Educational background includes a Bachelor of Pharmacy degree from The Hebrew University of Jerusalem.